Reduced Cytokine Release in Ex Vivo Response to Cilengitide...

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients

How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Cancers
DOI:
10.3390/cancers9090117
Date:
September, 2017
File:
PDF, 1005 KB
english, 2017
Conversion to is in progress
Conversion to is failed